Liver and biliary tract cancer trials in Argentina
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Ciudad Autónoma de Buenos Aires (caba), Córdoba, Rosario, San Miguel de Tucumán, San Salvador de Jujuy, Viedma
- Age
- 18 years and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Buenos Aires, Caba, Ciudad Autonoma Buenos Aires, Mar del Plata
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 2Taking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Buenos Aires, CABA, Rosario
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - No phaseTaking peopleEULAT Eradicate GBC
- Where
- Salta, San Salvador de Jujuy
- Age
- 18 years and over
- People
- 15,000 worldwide
- Run by
- Centre Paul Strauss
See details and how to joinNCT06192719 - No phaseTaking peopleThe CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
- Where
- Rosario
- Age
- 40 years to 75 years
- People
- 6,000 worldwide
- Run by
- Javier Toledo
See details and how to joinNCT06717295 - No phaseTaking peopleHepatocellular Carcinoma Identification Using Delta-HLD
- Where
- Mendoza
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Epiliquid Holding, Inc
See details and how to joinNCT07148310